FDA Inspection
Zhejiang Guobang Pharmaceutical Co., LtdZhejiang Guobang Pharmaceutical Co., Ltd – FDA Inspection, Mar 3, 2025
Record Details
This FDA Inspection record concerns Zhejiang Guobang Pharmaceutical Co., Ltd, with an inspection on March 3, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 5b7338a2-d174-4e34-b992-4588896f6c96
Inspection Facts
- Inspection number
- 1265595
- FDA center
- Human Drugs
Other FDA inspections of Zhejiang Guobang Pharmaceutical Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2018 | Not classified | Office of Inspections and Investigations | |
| September 24, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Guobang Pharmaceutical Co., Ltd
- FDA Inspection 1134720 - 2020-01-10
- FDA Inspection 1067561 - 2018-07-13
- FDA Inspection 945403 - 2015-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.